MedPath

Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks

Not Applicable
Completed
Conditions
Peripheral Nerve Blocks
Interventions
Device: Peripheral Nerve Blocks with CAIG
Registration Number
NCT02614222
Lead Sponsor
Clear Guide Medical
Brief Summary

The objective of this research is to determine if the addition of the Clear Guide ONE, a Computer Assisted Instrument Guidance (CAIG) system, provides improvement over existing ultrasound guided, needle-based procedures for peripheral nerve blocks. The ultrasound can visualize the targeted vessel or nerve, but the addition of the CAIG may help the clinician better guide the needle to the target.

Detailed Description

This pilot study will be a randomized, single-blinded control trial. The clinicians cannot be blinded, but the person questioning the patient post-op to determine success rate will be blinded. There will be two randomized groups of patients: control and test. The control group will receive the procedure with traditional methods and equipment currently in use at Cooper University. The test group will receive the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Undergoing orthopedic surgery who are candidates for peripheral nerve blocks for control of postoperative pain
  • Able to give written informed consent
Exclusion Criteria
  • Unable to give informed consent
  • Patients in whom regional anesthesia is contradicted

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Peripheral Nerve Block with CAIGPeripheral Nerve Blocks with CAIGThe participants in this group (test group) will utilize the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.
Primary Outcome Measures
NameTimeMethod
Time Needed to Correctly Identify the Neural Structure(s) and Induce the Peripheral Nerve BlockImmediately after intervention (within 2 hours)
Secondary Outcome Measures
NameTimeMethod
Clinician Rating of the DeviceImmediately following intervention (within 2 hours)

Clinician rates the device on a scale of 1-10. This also includes a questionnaire.

Number of Times Needle Needs RepositioningImmediately following intervention (within 2 hours)
Number of Patients That Needed Rescue OpioidsDuring hospital stay (maximum 3 days)
Number of AttemptsImmediately following intervention (within 2 hours)

Number of instrument pricks before target is reached

Patient Satisfaction Recorded on Post-op Day 1 Using QuestionnairePost-op day 1

Patient satisfaction will be recorded in the hospital or via phone on post-op day 1, on a 10-point scale (10 being most satisfied), using a questionnaire.

Incidence of Postoperative Nausea and VomitingDuring hospital stay (maximum 3 days)

Number of participants that reported postoperative nausea and vomiting

Undesired Muscle Weakness Measured SubjectivelyDuring hospital stay (maximum 3 days)

Number of participants that report undesired muscle weakness. Undesired muscle weakness will be measured subjectively - whether patient unable to ambulate and/or requiring the use of an immobilizer.

Trial Locations

Locations (1)

The Cooper Health System

🇺🇸

Camden, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath